Medtronic MDT
NYSE MDT
$93.72 -0.40 (-0.43%)
At close: Aug 20, 2026 · 11:13 AM UTC

Medtronic (MDT) Receivables - Other (2015 - 2016)

Medtronic (MDT) posted Receivables - Other of $261.0 million for Q2 2016, down 11.82% sequentially from $296.0 million in Q2 2015, and down 11.82% YoY from $296.0 million in Q2 2015.

Medtronic (MDT) Receivables - Other (2015 - 2016) Analysis & Trends

Medtronic has reported Receivables - Other for 2 years, with the latest figure at $261.0 million in Q2 2016.

  • Quarterly Receivables - Other fell 11.82% year-over-year to $261.0 million in Q2 2016, while the trailing twelve-month figure through Apr 2016 was $261.0 million (down 11.82% YoY) and the FY2016 annual result came in at $261.0 million, down 11.82% from the prior year.
  • Receivables - Other eased to $261.0 million in Q2 2016 per MDT's latest filing, from $296.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $296.0 million in Q2 2015 and troughed at $261.0 million in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Apr 29, 2016 261.00 Mn
Apr 29, 2016 261.00 Mn
Apr 24, 2015 296.00 Mn
Apr 24, 2015 296.00 Mn